Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2011 2
2013 1
2014 2
2015 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
The effect of CELLFOOD(TM) on radiotherapy or combined chemoradiotherapy: preclinical evidence.
Nuvoli B, Amadio B, Cortese G, Benedetti S, Antoniani B, Soriani A, Carosi M, Strigari L, Galati R. Nuvoli B, et al. Ther Adv Med Oncol. 2019 Oct 13;11:1758835919878347. doi: 10.1177/1758835919878347. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31662796 Free PMC article.
BACKGROUND: Based on previous observations that the nutraceutical CELLFOOD (CF), the 'physiological modulator' that aimed to make oxygen available 'on demand', inhibits the growth of cancer cells, this study was designed to investigate the role of CF in the regulation of h …
BACKGROUND: Based on previous observations that the nutraceutical CELLFOOD (CF), the 'physiological modulator' that aimed to make oxy …
CELLFOOD induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways.
Nuvoli B, Santoro R, Catalani S, Battistelli S, Benedetti S, Canestrari F, Galati R. Nuvoli B, et al. J Exp Clin Cancer Res. 2014 Mar 5;33(1):24. doi: 10.1186/1756-9966-33-24. J Exp Clin Cancer Res. 2014. PMID: 24598211 Free PMC article.
BACKGROUND: CELLFOOD (CF) is a nutraceutical non-addictive, non-invasive, and completely non-toxic unique proprietary colloidal-ionic formula. ...
BACKGROUND: CELLFOOD (CF) is a nutraceutical non-addictive, non-invasive, and completely non-toxic unique proprietary colloidal-ionic …
The antioxidant protection of CELLFOOD against oxidative damage in vitro.
Benedetti S, Catalani S, Palma F, Canestrari F. Benedetti S, et al. Food Chem Toxicol. 2011 Sep;49(9):2292-8. doi: 10.1016/j.fct.2011.06.029. Epub 2011 Jun 14. Food Chem Toxicol. 2011. PMID: 21703326
CELLFOOD (CF) is an innovative nutritional supplement containing 78 ionic/colloidal trace elements and minerals combined with 34 enzymes and 17 amino acids, all suspended in a solution of deuterium sulfate. ...
CELLFOOD (CF) is an innovative nutritional supplement containing 78 ionic/colloidal trace elements and minerals combined with 34 enzy
Cellfood improves respiratory metabolism of endothelial cells and inhibits hypoxia-induced reactive oxygen species (ros) generation.
Ferrero E, Fulgenzi A, Belloni D, Foglieni C, Ferrero ME. Ferrero E, et al. J Physiol Pharmacol. 2011 Jun;62(3):287-93. J Physiol Pharmacol. 2011. PMID: 21893688 Free article.
Both hypoxia and hyperoxia may favor the overproduction of ROS leading to oxidative stress, mitochondrial damage and endothelial dysfunction. We investigated the capability and mechanisms of Cellfood (CF), an antioxidant compound, to modulate O(2) availability and mitochon …
Both hypoxia and hyperoxia may favor the overproduction of ROS leading to oxidative stress, mitochondrial damage and endothelial dysfunction …
[Efficacy of Cellfood's therapy (deutrosulfazyme) in fibromyalgia].
Nieddu ME, Menza L, Baldi F, Frediani B, Marcolongo R. Nieddu ME, et al. Reumatismo. 2007 Oct-Dec;59(4):316-21. doi: 10.4081/reumatismo.2007.316. Reumatismo. 2007. PMID: 18157288 Free article. Clinical Trial. Italian.
OBJECTIVE: To assess the efficacy of Cellfood's therapy in the treatment of fibromyalgia. METHODS: This study was a single-blind, cross-over, randomized placebo-controlled trial. ...The patients were divided into two different-groups of thirty-one and nine subjects, each-o …
OBJECTIVE: To assess the efficacy of Cellfood's therapy in the treatment of fibromyalgia. METHODS: This study was a single-blind, cro …
Improvement of oxidative and metabolic parameters by cellfood administration in patients affected by neurodegenerative diseases on chelation treatment.
Fulgenzi A, De Giuseppe R, Bamonti F, Ferrero ME. Fulgenzi A, et al. Biomed Res Int. 2014;2014:281510. doi: 10.1155/2014/281510. Epub 2014 Jul 10. Biomed Res Int. 2014. PMID: 25114898 Free PMC article.
RESULTS: After 3-months' chelation+Cellfood administration oxLDL decreased, ROS levels were significantly lower, and TAC and glutathione levels were significantly higher than after chelation+other antioxidants treatment, both in ND patients and in controls. ...Although lim …
RESULTS: After 3-months' chelation+Cellfood administration oxLDL decreased, ROS levels were significantly lower, and TAC and glutathi …
Metabolism modifications and apoptosis induction after Cellfood administration to leukemia cell lines.
Catalani S, Carbonaro V, Palma F, Arshakyan M, Galati R, Nuvoli B, Battistelli S, Canestrari F, Benedetti S. Catalani S, et al. J Exp Clin Cancer Res. 2013 Sep 9;32(1):63. doi: 10.1186/1756-9966-32-63. J Exp Clin Cancer Res. 2013. PMID: 24016597 Free PMC article.
BACKGROUND: Cellfood (CF) is a nutritional supplement containing deuterium sulphate, minerals, amino acids, and enzymes, with well documented antioxidant properties. ...
BACKGROUND: Cellfood (CF) is a nutritional supplement containing deuterium sulphate, minerals, amino acids, and enzymes, with well do …
Efficacy of chelation therapy to remove aluminium intoxication.
Fulgenzi A, De Giuseppe R, Bamonti F, Vietti D, Ferrero ME. Fulgenzi A, et al. J Inorg Biochem. 2015 Nov;152:214-8. doi: 10.1016/j.jinorgbio.2015.09.007. Epub 2015 Sep 24. J Inorg Biochem. 2015. PMID: 26404567 Clinical Trial.
Such therapy further improved through daily treatment with the antioxidant Cellfood. In the present study we examined the efficacy of long-term treatment, using both EDTA and Cellfood. ...In conclusion, our data show the efficacy of chelation therapy associated with …
Such therapy further improved through daily treatment with the antioxidant Cellfood. In the present study we examined the efficacy of …